EstechPharma Co. Ltd Cash Flow Quality Index

Latest as of December 2025: 6.28x

EstechPharma Co. Ltd cash flow quality index. EstechPharma Co. Ltd (041910) has a Cash Flow Quality Index of 6.28x as of December 2025. Operating cash flow of ₩2.38 Billion exceeds net income of ₩379.07 Million, indicating high earnings quality where cash backs reported profits. See EstechPharma Co. Ltd financial flexibility index to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

6.28x
Operating CF / Net Income

Operating Cash Flow

₩2.38 Billion
KRW

Net Income

₩379.07 Million
KRW

Data as of

Dec 2025
Most recent filing

Cash Flow Quality Index of EstechPharma Co. Ltd (2013–2025)

Cash flow quality index of EstechPharma Co. Ltd from 2013 to 2025. Historical Cash Flow Quality Index for EstechPharma Co. Ltd across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore 041910 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.

EstechPharma Co. Ltd Cash Flow Quality Index by Year (2013–2025)

EstechPharma Co. Ltd cash flow quality index by year from 2013 to 2025. Year-by-year earnings quality comparison for EstechPharma Co. Ltd. For the full cash flow conversion analysis, see EstechPharma Co. Ltd (041910) cash conversion ratio.

Year Quality Index Operating CF (KRW) Net Income YoY Change
2025 1.43x ₩8.83 Billion ₩6.16 Billion ▼ -28.6%
2024 2.01x ₩7.93 Billion ₩3.95 Billion ▲ +60.4%
2023 1.25x ₩4.79 Billion ₩3.82 Billion ▲ +1326.9%
2021 0.09x ₩603.42 Million ₩6.87 Billion ▼ -79.6%
2020 0.43x ₩4.71 Billion ₩10.96 Billion ▲ +52.5%
2019 0.28x ₩4.29 Billion ₩15.23 Billion ▼ -74.4%
2018 1.10x ₩7.25 Billion ₩6.59 Billion ▼ -57.1%
2017 2.56x ₩6.99 Billion ₩2.73 Billion ▲ +29.9%
2016 1.97x ₩8.19 Billion ₩4.15 Billion ▲ +237.5%
2014 0.58x ₩4.99 Billion ₩8.54 Billion ▼ -78.8%
2013 2.75x ₩10.19 Billion ₩3.70 Billion —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.